Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00534521 · ClinicalTrials.gov registry record · Phase 3
Posterior Tibial Nerve Stimulation vs. Sham
A Phase 3 study, sponsored by Corewell Health East.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00534521 is a Phase 3 study that has completed, run by Corewell Health East. The registered enrollment target is 30 participants.
The verdict
NCT00534521, a Phase 3 study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The overall goal of this research is to determine the efficacy of a sham for posterior tibial nerve stimulation (PTNS). This novel design is needed in order to have a sham treatment that is similar to the actual treatment. The PTNS is used to treat urgency and frequency in people with overactive bladder (OAB). Until research is done using a sham component, we are unable to ascertain if the current use of PTNS is due to a placebo effect.
Interventions
- DEVICE Sham
- DEVICE Posterior Tibial Nerve Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-09 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00534521
The ClinicalTrials.gov registry entry for NCT00534521 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT00534521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00534521 about?
NCT00534521 is a clinical study titled "Posterior Tibial Nerve Stimulation vs. Sham". The overall goal of this research is to determine the efficacy of a sham for posterior tibial nerve stimulation (PTNS). This novel design is needed in order to have a sham treatment that is similar to the actual treatment. The PTNS is used to treat urgency and frequency in people with overactive bla...
What is the current status of trial NCT00534521?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2007-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00534521?
The interventions under investigation include: Sham (DEVICE), Posterior Tibial Nerve Device (DEVICE).
Who is sponsoring clinical trial NCT00534521?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.